{
    "2019-07-19": [
        [
            {
                "time": "",
                "original_text": "医药股走弱，次新股翰森制药跌超4%",
                "features": {
                    "keywords": [
                        "医药股",
                        "次新股",
                        "翰森制药",
                        "下跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【健康界产业周刊】又一家二甲双胍过一致性评价 科创板生物医药第一股落地",
                "features": {
                    "keywords": [
                        "健康界",
                        "二甲双胍",
                        "一致性评价",
                        "科创板",
                        "生物医药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中生制药反弹逾3% 旗下降糖药获批通过一致性评价",
                "features": {
                    "keywords": [
                        "中生制药",
                        "反弹",
                        "降糖药",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "仿制药一致性评价最新进展：受理号达1289个 通过308个",
                "features": {
                    "keywords": [
                        "仿制药",
                        "一致性评价",
                        "受理号",
                        "通过"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "未通过一致性评价的药品市场洗牌进入白热化阶段",
                "features": {
                    "keywords": [
                        "一致性评价",
                        "药品市场",
                        "洗牌",
                        "白热化"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "9家A股上市公司有意分拆子公司“闯关”科创板",
                "features": {
                    "keywords": [
                        "A股",
                        "上市公司",
                        "分拆",
                        "子公司",
                        "科创板"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}